Seaport Therapeutics宣布,其Glyphallo药物的Buoy-1 Phase 2B临床试验已正式开启患者入组工作。该公司预计,该试验的顶线数据将于2027年上半年公布。
Seaport Therapeutics宣布,其Glyphallo药物的Buoy-1 Phase 2B临床试验已正式开启患者入组工作。该公司预计,该试验的顶线数据将于2027年上半年公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.